+44 1625708989Evaluating Guideline Directed Medical Therapy (GDMT) in Yemeni�s Patients with Heart Failure
Author(s): Ali Alyahawi1* , Khalid Al-Adeeb2 , Abdulsalam Halboup3 , Ayed Al ShammariBackground: Heart failure is a multi-faceted and life threating syndrome. In the management of CHF, a gap between Guideline Directed Medical Therapy (GDMT) and actual practice has been reported. An increase in the prevalence of co-morbid conditions and risk factors, such as increased Body Mass Index (BMI), metabolic syndrome and cigarette smoking may be some of the reasons behind the increased prevalence of HF. Aims of the study: The aims of this study are to discover the behavior of Yemeni cardiologists in treating patients with HF regarding new guideline.
Materials and Methods: This prospective study was performed at several cardiology clinics and centers in Sanaa city. Patients’ profile and prescriptions were used to collect the data by interviewing the patients and reviewing their prescriptions. A total of 177 patients with the 15 cardiology specialists and consultants were included in the current study. All data analyzed using SPSS statistics version 21.0.
Results: We found a low percentage (30.1%) of the patients were prescribed the optimum guideline directed medical therapy and the low rate of ARNi (30.1%) and SGLT2i (34.1%) prescription indicate low implication of 2022 HF guideline in Yemeni patients.
Conclusion: Yemeni patients need more help to benefit them from the guideline like more education and clinical pharmacy engagement in the treatment and telemedicine.
PDF